These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Endothelial nitric oxide in diabetes mellitus: too much or not enough? Farkas K; Sármán B; Jermendy G; Somogyi A Diabetes Nutr Metab; 2000 Oct; 13(5):287-97. PubMed ID: 11105972 [TBL] [Abstract][Full Text] [Related]
3. The endothelial dysfunction in diabetes mellitus. Pănuş C; Moţa M; Vladu D; Vanghelie L; Răducanu CL Rom J Intern Med; 2003; 41(1):27-33. PubMed ID: 15529582 [TBL] [Abstract][Full Text] [Related]
4. [Endothelial function and the microcirculation in diabetes mellitus]. Arosio E; Minuz P; Prior M Ann Ital Med Int; 1999; 14(2):106-13. PubMed ID: 10399372 [TBL] [Abstract][Full Text] [Related]
5. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus. Guerci B; Böhme P; Kearney-Schwartz A; Zannad F; Drouin P Diabetes Metab; 2001 Sep; 27(4 Pt 1):436-47. PubMed ID: 11547217 [TBL] [Abstract][Full Text] [Related]
7. Endothelial dysfunction, atherosclerosis and diabetes. Najemnik C; Sinzinger H; Kritz H Acta Med Austriaca; 1999; 26(5):148-53. PubMed ID: 11512191 [TBL] [Abstract][Full Text] [Related]
8. Why does diabetes mellitus increase the risk of cardiovascular disease? Shahab A Acta Med Indones; 2006; 38(1):33-41. PubMed ID: 16479030 [TBL] [Abstract][Full Text] [Related]
9. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Cersosimo E; DeFronzo RA Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274 [TBL] [Abstract][Full Text] [Related]
10. Reactive oxygen-derived free radicals are key to the endothelial dysfunction of diabetes. Shi Y; Vanhoutte PM J Diabetes; 2009 Sep; 1(3):151-62. PubMed ID: 20923534 [TBL] [Abstract][Full Text] [Related]
11. Vascular growth factors and the development of macrovascular disease in diabetes mellitus. Koschinsky T; Bünting CE; Rütter R; Gries FA Diabete Metab; 1987 Jul; 13(3 Pt 2):318-25. PubMed ID: 3308559 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes. Rask-Madsen C; King GL Nat Clin Pract Endocrinol Metab; 2007 Jan; 3(1):46-56. PubMed ID: 17179929 [TBL] [Abstract][Full Text] [Related]
13. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in metabolic disorders: hypercholesterolaemia and diabetes]. Strawn WB Drugs; 2002; 62 Spec No 1():31-41. PubMed ID: 12036387 [TBL] [Abstract][Full Text] [Related]
14. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes. Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779 [TBL] [Abstract][Full Text] [Related]
15. Nitric oxide and vascular responses in Type I diabetes. Chan NN; Vallance P; Colhoun HM Diabetologia; 2000 Feb; 43(2):137-47. PubMed ID: 10753034 [TBL] [Abstract][Full Text] [Related]
16. Current perspective. Diabetic vascular disease: from endothelial dysfunction to atherosclerosis. Candido R; Zanetti M Ital Heart J; 2005 Sep; 6(9):703-20. PubMed ID: 16212072 [TBL] [Abstract][Full Text] [Related]